Connor Clark & Lunn Investment Management Ltd. Invests $9.70 Million in Revvity Inc. $RVTY

Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Revvity Inc. (NYSE:RVTY) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 87,145 shares of the company’s stock, valued at approximately $9,696,000. Connor Clark & Lunn Investment Management Ltd. owned about 0.08% of Revvity as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. AQR Capital Management LLC raised its holdings in Revvity by 5.2% in the 1st quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock worth $883,000 after acquiring an additional 420 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Revvity by 6.7% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock valued at $1,246,000 after purchasing an additional 744 shares during the last quarter. Millennium Management LLC boosted its stake in Revvity by 102.0% during the 1st quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock valued at $7,343,000 after purchasing an additional 35,048 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of Revvity by 45.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock worth $64,232,000 after purchasing an additional 189,871 shares in the last quarter. Finally, Focus Partners Wealth increased its holdings in shares of Revvity by 13.0% in the 1st quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock worth $744,000 after purchasing an additional 811 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on RVTY. JPMorgan Chase & Co. decreased their price target on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. Barclays increased their price objective on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. Evercore reissued an “outperform” rating on shares of Revvity in a research report on Wednesday, August 5th. Stifel Nicolaus lowered their target price on shares of Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research note on Wednesday, May 6th. Finally, Robert W. Baird set a $117.00 price target on shares of Revvity in a report on Wednesday, May 6th. Three equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $108.36.

Revvity Stock Up 1.2%

RVTY stock opened at $126.31 on Thursday. The company has a market cap of $14.09 billion, a price-to-earnings ratio of 60.15, a P/E/G ratio of 2.27 and a beta of 1.07. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80. The business’s 50-day moving average is $112.94 and its two-hundred day moving average is $100.82. Revvity Inc. has a fifty-two week low of $81.22 and a fifty-two week high of $126.90.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The business had revenue of $729.69 million during the quarter, compared to the consensus estimate of $702.96 million. During the same period in the previous year, the company posted $1.18 EPS. The business’s quarterly revenue was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, analysts forecast that Revvity Inc. will post 5.36 earnings per share for the current year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. Revvity’s dividend payout ratio (DPR) is presently 13.33%.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.